| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC20364 | DNS-pE2 | DNS-pE2 is the first small molecule that can selectively label endogenous 3-phosphoglycerate dehydrogenase (PHGDH) from various mammalian cells. |
|
| DC11464 | DO-264 Featured | DO264 is an inhibitor of α/β-hydrolase domain-containing protein 12 (ABHD12; IC50 = 11 nM).It inhibits ABHD12-dependent hydrolysis of lysophosphatidylserine (lyso-PS) in mouse brain membrane lysates (IC50 = 2.8 nM) and human THP-1 cells. |
|
| DC20136 | DO34 analog | DO34 analog is a triazole DAGL(α) inhibitor extracted from patent WO2017096315 A1, compound 100. |
|
| DC20960 | DO-34 | DO-34 is a highly potent dual DAGLα/β inhibitor with IC50 of 6 nM 3-8 nM, respectively. |
|
| DC8416 | Docetaxel Trihydrate | Docetaxel, an analog of paclitaxel, is an inhibitor of depolymerisation of microtubules by binding to stabilized microtubules. |
|
| DC4187 | Docetaxel Featured | Docetaxel, an analog of taxol, is an inhibitor of depolymerisation of microtubules through binding to stabilized microtubules. |
|
| DCAPI1299 | Docosanol (Abreva) | Docosanol (Abreva) |
|
| DC12208 | Docosapentaenoic acid 22n-3 | Docosapentaenoic acid (22n-3) is a component of phospholipids found in all animal cell membranes. |
|
| DC10247 | Docusate Sodium | Docusate Sodium is a laxative used to treat constipation, for constipation due to the use of opiates it maybe used with a stimulant laxative, can be taken by mouth or rectally. |
|
| DC9648 | Dodecanoic acid ingenol ester Featured | Dodecanoic acid ingenol ester is a natural compound. |
|
| DC12216 | Dodecanoylcarnitine Featured | Dodecanoylcarnitine is present in fatty acid oxidation disorders such as long-chain acyl CoA dehydrogenase deficiency, carnitine palmitoyltransferase I/II deficiency, and is also associated with celiac disease. |
|
| DC9588 | Dofequidar (fumarate) | Dofequidar fumarate(MS-209 fumarate), an orally active quinoline compound, has been reported to overcome MDR by inhibiting ABCB1/P-gp, ABCC1/MDR-associated protein 1, or both. |
|
| DCAPI1022 | Dofetilide (Tikosyn) Featured | Dofetilide (Tikosyn) |
|
| DC9323 | Dalasetron (Mesylate hydrate) | Dolasetron(MDL-73147) is a serotonin 5-HT3 receptor antagonist used to treat nausea and vomiting following chemotherapy. |
|
| DC7273 | Dolutegravir Featured | Dolutegravir (DTG, GSK1349572) is an integrase inhibitor(IC50= 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H. |
|
| DC10250 | Dolutegravir Sodium Featured | Dolutegravir is a HIV integrase inhibitor with IC50 of 2.7 nM. |
|
| DC9133 | Domperidone | Domperidone is a dopamine blocker and an antidopaminergic reagent. |
|
| DC3155 | Donepezil hydrochloride Featured | Donepezil is a specific and potent AChE inhibitor for bAChE and hAChE with IC50 of 8.12 nM and 11.6 nM , respectively. |
|
| DC9102 | Donepezil | Donepezil(E 2020) is a specific and potent AChE inhibitor for bAChE and hAChE with IC50 of 8.12 nM and 11.6 nM, respectively. |
|
| DC11103 | Tavapadon Featured | Tavapadon is a potent, orally-bioavailable, selective partial agonist of the dopamine D1 and D5 receptors. |
|
| DC9308 | Doravirine (MK-1439) Featured | Doravirine (MK-1439) is a non-nucleoside reverse transcriptase inhibitor. |
|
| DCAPI1164 | Doripenem Hydrate | Doripenem Hydrate |
|
| DC20365 | Dorrigocin A | Dorrigocin A is a natural compound that shows potent antiproliferative effect on tumor cell line.. |
|
| DC7115 | Dorsomorphin dihydrochloride Featured | Dorsomorphin 2Hcl (Compound C; BML-275) has been shown to act as a potent and selective inhibitor of AMPK (AMP-activated protein kinase; Ki = 109 nM), induced by AICAR and metformin; also inhibits ALK2, ALK3, and ALK 6 . |
|
| DC4219 | Dorzolomide hydrochloride | Dorzolamide HCl is a carbonic anhydrase inhibitor. |
|
| DC20057 | Dot1L-IN-1 | Dot1L-IN-1 is a highly potent, selective and structurally novel Dot1L inhibitor with a Ki of 2 pM. |
|
| DC21895 | DOTA-ADIBO | DOTA-ADIBO is a Click Chemistry intermidate used for antibody-drug conjugates.. |
|
| DC3142 | Dovitinib Dilacticacid Featured | Dovitinib (TKI258, CHIR-258) is a multitargeted tyrosine kinase inhibitor of FLT3 and c-KIT with IC50 of 1 nM and 2 nM, respectively. |
|
| DC4157 | Dovitinib (TKI258, CHIR258) Featured | Dovitinib (TKI258, CHIR258) is a novel multi-target inhibitor for Flt3, c-Kit, FGFR1/3, VEGFR1/2/3, PDGFRα/β with IC50 of 1 nM, 2 nM, 8 nM/9 nM and 10 nM/13 nM/8 nM, 210 nM/27 nM respectively. |
|
| DC3141 | Dovitinib (TKI258) Lactate Featured | Dovitinib (TKI258, CHIR258) is a novel multi-target inhibitor for Flt3, c-Kit, FGFR1/3, VEGFR1/2/3, PDGFRα/β with IC50 of 1 nM, 2 nM, 8 nM/9 nM and 10 nM/13 nM/8 nM, 210 nM/27 nM respectively. |
|
